Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT00424502
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* diagnosed RA for \>=3 months prior to first administration of study medication;
* inadequate response or intolerance to \>=1 anti-TNF therapies, alone or in combination with methotrexate;
* if using NSAIDS, analgesics or oral corticosteroids, must be on a stable dose for \>=2 weeks prior to start of study.
Exclusion Criteria:
* other chronic inflammatory diseases;
* use of parental corticosteroids within 4 weeks prior to screening;
* severe heart failure, or severe, uncontrolled cardiac disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00424502
Study Brief:
Protocol Section:
NCT00424502